Icon

ZONTIVITY - (2.08MG)

VORAPAXAR SULFATE None
2.08MG
Less Than $1000 mn
None None
None None
None None
ZONTIVITY is a protease-activated receptor-1 (PAR-1) antagonist indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD).
Yes
ZONTIVITY Patent 1 Patent 2 Patent 3
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.